Skip to content

Find a medicine
Patients support program
Follow Us
Linkedin
YouTube

About Us
Patients
Products
Careers
Stay and read
Contact Us
Eng
Por
Esp

Pharma Industry Insights

Nutritional Pharma

Innovative Medicines Group & GHN

19 de September de 2024 | Pharma, Pharma Industry Insights

Innovative Medicines Group & GHN

By Ingenima

Contact

Alejandra Saldaña
Science Park, Platinum Building Of. BC 19
Ruta 101 Km 23.500, 14000, Canelones
Uruguay
Tel: +598 2682 9862
asaldana@imedicinesgroup.com

TERMS OF USE – PRIVACY POLICY

Pharmacovigilance

We implement robust regional medical programs.

For further information on any product or activity, please reach out to our medical team at medicalinquiries@imedicinesgroup.com

Medical Inquiries

We run regional medical programs.

If you require additional information on any product or activity, please contact our medical team at medicalinquires@imedicinesgroup.com

Compliance

IMG is committed to long-term, sustainable growth, with clear and transparent ways of creating and delivering value to physicians and patients. We work hard every day to generate a positive impact for society.

IMG’s objectives are:
(i) Development and implementation of honest behaviors and control processes in accordance with international compliance standards.
(ii) Prevention and early detection of breaches of any law or regulation.

IMG encourages strict adherence to its Code of Conduct & Ethics. In our program, it is imperative to make ethical decisions in all aspects of business. As a service provider, we are committed to maintain the trust that IMG has earned from patients and other stakeholders. We are passionate about creating value for patients, patient safety, quality of our products, and our ethics and compliance. An independent team will develop proactive monitoring of business activities and processes which may provide opportunities for risk identification and early detection. This independent team of experts will continually develop online and in-person training and communications covering ethics and compliance-related risk areas. The main focus is:
(i) Healthcare compliance – interactions with healthcare professionals
(ii) Data privacy
(iii) Anti-bribery
(iv) Anti-corruption
(v) Transparency